Sven-Erik Strand
51 – 60 of 184
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
A small-scale anatomical dosimetry model of the liver.
Stenvall, Anna LU ; Larsson, Erik LU ; Strand, Sven-Erik LU and Jönsson, Bo-Anders LU
(2014)
In Physics in Medicine and Biology
59(13).
p.3353-3371
- Contribution to journal › Article
-
Mark
Testis dosimetry in individual patients by combining a small-scale dosimetry model and pharmacokinetic modeling-application of (111)In-Ibritumomab Tiuxetan (Zevalin(®)).
Meerkhan, Suaad LU ; Sjögreen Gleisner, Katarina LU ; Larsson, Erik LU ; Strand, Sven-Erik LU and Jönsson, Bo-Anders LU
(2014)
In Physics in Medicine and Biology
59(24).
p.7889-7904
- Contribution to journal › Article
-
Mark
Optimizing retention of multimodal imaging nanostructures in sentinel lymph nodes by nanoscale size tailoring.
Kjellman, Pontus LU ; in 't Zandt, René LU
; Fredriksson, Sarah
and Strand, Sven-Erik
LU
(2014)
In Nanomedicine: Nanotechnology, Biology and Medicine
10(5).
p.1089-1095
- Contribution to journal › Article
-
Mark
Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer.
Evans Axelsson, Susan LU
; Vilhelmsson Timmermand, Oskar
LU
; Welinder, Charlotte
LU
; Borrebaeck, Carl Ak
; Strand, Sven-Erik
LU
; Tran, Thuy
LU
; Jansson, Bo
LU
and Bjartell, Anders
LU
(2014)
In American journal of nuclear medicine and molecular imaging
4(4).
p.311-323
- Contribution to journal › Article
-
Mark
Development of a Hybrid Nanoprobe for Triple-Modality MR/SPECT/Optical Fluorescence Imaging
Madru, Renata LU ; Svenmarker, Pontus LU ; Ingvar, Christian LU ; Ståhlberg, Freddy LU ; Andersson-Engels, Stefan LU ; Knutsson, Linda LU
and Strand, Sven-Erik
LU
(2014)
In Diagnostics
4(1).
p.13-26
- Contribution to journal › Article
-
Mark
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors : preclinical assessment
(2014) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 55(11). p.8-1842
- Contribution to journal › Article
-
Mark
In vivo evaluation of 177Lu-labeled h11B6, a humanized antibody for hK2 targeting in prostate cancer
Vilhelmsson Timmermand, Oskar LU
; Larsson, Erik
LU
; Strand, Sven-Erik
LU
and Tran, Thuy
LU
(2014)
In Journal of Nuclear Medicine
55(Supplement 1).
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
The Intratumoral Distribution of Radiolabeled 177Lu-BR96 Monoclonal Antibodies Changes in Relation to Tumor Histology over Time in a Syngeneic Rat Colon Carcinoma Model.
Örbom, Anders LU
; Eriksson, Sophie
LU
; Elgström, Erika
LU
; Ohlsson, Tomas G
LU
; Nilsson, Rune
LU
; Tennvall, Jan
LU
and Strand, Sven-Erik
LU
(2013)
In Journal of Nuclear Medicine
54(8).
p.1404-1410
- Contribution to journal › Article
-
Mark
Preclinical radioimmunotherapy of prostate cancer with 177Lu-11B6, a 177Lu-labeled monoclonal antibody specifically targeting free, unbound human kallikrein-related peptidase 2
Vilhelmsson Timmermand, Oskar LU
; Tran, Thuy
LU
; Larsson, Erik
LU
; Pettersson, Kim
; Lilja, Hans Gösta
LU
; Ulmert, David
LU
and Strand, Sven-Erik
LU
(2013)
In Journal of Nuclear Medicine
54(Supplement 2).
- Contribution to journal › Published meeting abstract
- 2012
-
Mark
Targeting Free Prostate-Specific Antigen for In Vivo Imaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone.
Evans Axelsson, Susan LU
; Ulmert, David
LU
; Örbom, Anders
LU
; Peterson, Pernilla
LU
; Nilsson, Olle
; Wennerberg, Johan
LU
; Strand, Joanna
LU
; Wingårdh, Karin
LU
; Olsson, Tomas
LU
and Hagman, Zandra
LU
, et al.
(2012)
In Cancer Biotherapy & Radiopharmaceuticals
27(4).
p.243-251
- Contribution to journal › Article